These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 37832977)
1. Reperfusion and cytoprotective agents are a mutually beneficial pair in ischaemic stroke therapy: an overview of pathophysiology, pharmacological targets and candidate drugs focusing on excitotoxicity and free radical. Xu X; Chen M; Zhu D Stroke Vasc Neurol; 2024 Aug; 9(4):351-359. PubMed ID: 37832977 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological brain cytoprotection in acute ischaemic stroke - renewed hope in the reperfusion era. Fisher M; Savitz SI Nat Rev Neurol; 2022 Apr; 18(4):193-202. PubMed ID: 35079135 [TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic targets for reperfusion injury in ischemic stroke: Understanding the role of mitochondria, excitotoxicity and ferroptosis. Awasthi VA; Dhankar V; Singh S Vascul Pharmacol; 2024 Sep; 156():107413. PubMed ID: 39059676 [TBL] [Abstract][Full Text] [Related]
4. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury. Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084 [TBL] [Abstract][Full Text] [Related]
5. Neuroprotection in cerebral ischaemia: facts and fancies--the need for new approaches. Wahlgren NG; Ahmed N Cerebrovasc Dis; 2004; 17 Suppl 1():153-66. PubMed ID: 14694293 [TBL] [Abstract][Full Text] [Related]
6. Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy. Sun MS; Jin H; Sun X; Huang S; Zhang FL; Guo ZN; Yang Y Oxid Med Cell Longev; 2018; 2018():3804979. PubMed ID: 29770166 [TBL] [Abstract][Full Text] [Related]
7. The protective effects of Axitinib on blood-brain barrier dysfunction and ischemia-reperfusion injury in acute ischemic stroke. Wang K; Zhou W; Wen L; Jin X; Meng T; Li S; Hong Y; Xu Y; Yuan H; Hu F Exp Neurol; 2024 Sep; 379():114870. PubMed ID: 38897539 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues-Liraglutide and Semaglutide. Basalay MV; Davidson SM; Yellon DM Cardiovasc Drugs Ther; 2019 Dec; 33(6):661-667. PubMed ID: 31721014 [TBL] [Abstract][Full Text] [Related]
9. Natural medicine in neuroprotection for ischemic stroke: Challenges and prospective. Tao T; Liu M; Chen M; Luo Y; Wang C; Xu T; Jiang Y; Guo Y; Zhang JH Pharmacol Ther; 2020 Dec; 216():107695. PubMed ID: 32998014 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotection for ischaemic stroke: current status and challenges. Moretti A; Ferrari F; Villa RF Pharmacol Ther; 2015 Feb; 146():23-34. PubMed ID: 25196155 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel model of global forebrain ischaemia-reperfusion injury in mice and comparison with focal ischaemic and haemorrhagic stroke. Lee NT; Selan C; Chia JSJ; Sturgeon SA; Wright DK; Zamani A; Pereira M; Nandurkar HH; Sashindranath M Sci Rep; 2020 Oct; 10(1):18170. PubMed ID: 33097782 [TBL] [Abstract][Full Text] [Related]
12. Novel arylidene malonate derivative, KM-34, showed neuroprotective effects on in vitro and in vivo models of ischemia/reperfusion. Ramírez-Sánchez J; Wong-Guerra M; Fonseca-Fonseca LA; Simões-Pires EN; García-Pupo L; Ochoa-Rodríguez E; Verdecia-Reyes Y; Delgado-Hernández R; Salbego C; Souza DO; Pardo-Andreu GL; Nuñez-Figueredo Y Eur J Pharmacol; 2021 May; 899():174025. PubMed ID: 33722590 [TBL] [Abstract][Full Text] [Related]
14. Autophagy Elicits Neuroprotection at the Subacute Phase of Transient Cerebral Ischaemia but Has Few Effects on Neurological Outcomes After Permanent Ischaemic Stroke in Rats. Guo T; Deng YH; Dong LL; Ren L; He HY Curr Med Sci; 2021 Aug; 41(4):803-814. PubMed ID: 34403106 [TBL] [Abstract][Full Text] [Related]
15. Development of endothelial-targeted CD39 as a therapy for ischemic stroke. Lee NT; Savvidou I; Selan C; Calvello I; Vuong A; Wright DK; Brkljaca R; Willcox A; Chia JSJ; Wang X; Peter K; Robson SC; Medcalf RL; Nandurkar HH; Sashindranath M J Thromb Haemost; 2024 Aug; 22(8):2331-2344. PubMed ID: 38754782 [TBL] [Abstract][Full Text] [Related]
16. Anti-ischemia/reperfusion injury effects of notoginsenoside R1 on small molecule metabolism in rat brain after ischemic stroke as visualized by MALDI-MS imaging. Zhu T; Wang L; Tian F; Zhao X; Pu XP; Sun GB; Sun XB Biomed Pharmacother; 2020 Sep; 129():110470. PubMed ID: 32768957 [TBL] [Abstract][Full Text] [Related]
19. A new idea about reducing reperfusion injury in ischemic stroke: Gradual reperfusion. Shi J; Liu Y; Duan Y; Sun Z; Wang B; Meng R; Ji X Med Hypotheses; 2013 Feb; 80(2):134-6. PubMed ID: 23232107 [TBL] [Abstract][Full Text] [Related]
20. Baicalein exerts neuroprotective effect against ischaemic/reperfusion injury via alteration of NF-kB and LOX and AMPK/Nrf2 pathway. Yuan Y; Men W; Shan X; Zhai H; Qiao X; Geng L; Li C Inflammopharmacology; 2020 Oct; 28(5):1327-1341. PubMed ID: 32418004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]